Flow cytometric enumeration of CD34(+) hematopoietic stem and progenitor ce
lls (HPC) is widely used for evaluation of graft adequacy of peripheral blo
od stem cell grafts, and is also useful in planning the apheresis sessions
necessary to obtain these grafts. The state-of-the-art method to enumerate
CD34(+) cells makes use of a multiparameter definition of HPC based on thei
r light scatter characteristics and dim expression of CD45, and the use of
counting beads to derive the concentration of CD34(+) cells directly from t
he flow cytometric assessment. This method can be extended with a viability
stain and additional markers for further immunological characterization of
CD34(+) cells, and has been successfully implemented in multicenter trials
. Thus, the lower threshold of a safe HPC graft in terms of short- and long
-term hematopoiesis may be more accurately defined.